Tuesday, October 6, 2026

BTC $85,642 ▼ 0.03%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

BTC$85,642−0.03%ETH$2,703−0.00%SOL$120.12−0.23%XRP$1.50−0.00%LINK$13.83−1.84%ADA$0.271+1.00%S&P 5007,774+0.66%Nasdaq27,477+1.05%Dow51,268+0.18%RUT2,847+0.50%TNX5.31%+0.64%TYX5.67%+0.62%FVX5.07%+0.22%IRX4.02%+0.63%VIX15.52+1.37%GOLD$4,148.70−0.19%SILVER$60.73−0.93%OIL$89.76+0.37%DXY102.20+0.03%NVDA$238.90+2.12%AAPL$332.89−0.24%TSLA$378.73+2.20%META$741.90+1.90%MSFT$525.18+1.48%AMZN$251.40−0.05%GOOGL$346.47+0.86%Fear & Greed73 — GreedBTC$85,642−0.03%ETH$2,703−0.00%SOL$120.12−0.23%XRP$1.50−0.00%LINK$13.83−1.84%ADA$0.271+1.00%S&P 5007,774+0.66%Nasdaq27,477+1.05%Dow51,268+0.18%RUT2,847+0.50%TNX5.31%+0.64%TYX5.67%+0.62%FVX5.07%+0.22%IRX4.02%+0.63%VIX15.52+1.37%GOLD$4,148.70−0.19%SILVER$60.73−0.93%OIL$89.76+0.37%DXY102.20+0.03%NVDA$238.90+2.12%AAPL$332.89−0.24%TSLA$378.73+2.20%META$741.90+1.90%MSFT$525.18+1.48%AMZN$251.40−0.05%GOOGL$346.47+0.86%Fear & Greed73 — Greed

Tag

drug approval

1 article

U.S. Equities40d ago

Revolution Medicines' Rasonque Wins FDA Nod in Pancreatic Cancer

Daraxonrasib cleared 6.5 months early with Phase 3 data showing median 13.2-month survival versus 6.7 months on chemotherapy in second-line metastatic pancreatic cancer.